{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:47:17Z","timestamp":1789753637534,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s12035-021-02525-4","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:28:56Z","timestamp":1629934136000},"page":"6020-6031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6141-3592","authenticated-orcid":false,"given":"Jayantee","family":"Kalita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8035-9181","authenticated-orcid":false,"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasudev","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha K.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"issue":"2","key":"2525_CR1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/ng0295-210","volume":"9","author":"GR Thomas","year":"1995","unstructured":"Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW (1995) The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 9(2):210\u2013217. https:\/\/doi.org\/10.1038\/ng0295-210","journal-title":"Nat Genet"},{"issue":"2","key":"2525_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00439-006-0202-5","volume":"120","author":"P Ferenci","year":"2006","unstructured":"Ferenci P (2006) Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 120(2):151\u2013159. https:\/\/doi.org\/10.1007\/s00439-006-0202-5","journal-title":"Hum Genet"},{"issue":"2","key":"2525_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.30911","volume":"71","author":"TD Sandahl","year":"2020","unstructured":"Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P (2020) The prevalence of Wilson\u2019s disease: an update. Hepatology 71(2):722\u2013732. https:\/\/doi.org\/10.1002\/hep.30911","journal-title":"Hepatology"},{"issue":"1","key":"2525_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","volume":"4","author":"A Czlonkowska","year":"2018","unstructured":"Czlonkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, et al (2018) Wilson disease. Nat Rev Dis Prim 4(1):21. https:\/\/doi.org\/10.1038\/s41572-018-0018-3","journal-title":"Nat Rev Dis Prim"},{"issue":"3","key":"2525_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"European Association for Study of L","year":"2012","unstructured":"European Association for Study of L (2012) EASL Clinical Practice Guidelines: Wilson\u2019s disease. J Hepatol 56(3):671\u2013685. https:\/\/doi.org\/10.1016\/j.jhep.2011.11.007","journal-title":"J Hepatol"},{"issue":"3","key":"2525_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gut.46.3.415","volume":"46","author":"PJ Gow","year":"2000","unstructured":"Gow PJ, Smallwood RA, Angus PW, Smith AL, Wall AJ, Sewell RB (2000) Diagnosis of Wilson\u2019s disease: an experience over three decades. Gut 46(3):415\u2013419. https:\/\/doi.org\/10.1136\/gut.46.3.415","journal-title":"Gut"},{"issue":"7","key":"2525_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/2045125318759461","volume":"8","author":"T Litwin","year":"2018","unstructured":"Litwin T, Dusek P, Szafranski T, Dziezyc K, Czlonkowska A, Rybakowski JK (2018) Psychiatric manifestations in Wilson\u2019s disease: possibilities and difficulties for treatment. Ther Adv Psychopharmacol 8(7):199\u2013211. https:\/\/doi.org\/10.1177\/2045125318759461","journal-title":"Ther Adv Psychopharmacol"},{"key":"2525_CR8","first-page":"171","volume":"65","author":"M Akil","year":"1995","unstructured":"Akil M, Brewer GJ (1995) Psychiatric and behavioral abnormalities in Wilson\u2019s disease. Adv Neurol 65:171\u2013178","journal-title":"Adv Neurol"},{"issue":"1\u20132","key":"2525_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jns.2007.09.009","volume":"266","author":"K Srinivas","year":"2008","unstructured":"Srinivas K, Sinha S, Taly AB, Prashanth LK, Arunodaya GR, Janardhana Reddy YC, Khanna S (2008) Dominant psychiatric manifestations in Wilson\u2019s disease: a diagnostic and therapeutic challenge! J Neurol Sci 266(1\u20132):104\u2013108. https:\/\/doi.org\/10.1016\/j.jns.2007.09.009","journal-title":"J Neurol Sci"},{"key":"2525_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clineuro.2015.07.013","volume":"138","author":"A Ranjan","year":"2015","unstructured":"Ranjan A, Kalita J, Kumar S, Bhoi SK, Misra UK (2015) A study of MRI changes in Wilson disease and its correlation with clinical features and outcome. Clin Neurol Neurosurg 138:31\u201336. https:\/\/doi.org\/10.1016\/j.clineuro.2015.07.013","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2525_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3174\/ajnr.A5936","volume":"40","author":"XE Yu","year":"2019","unstructured":"Yu XE, Gao S, Yang RM, Han YZ (2019) MR imaging of the brain in neurologic Wilson disease. AJNR Am J Neuroradiol 40(1):178\u2013183. https:\/\/doi.org\/10.3174\/ajnr.A5936","journal-title":"AJNR Am J Neuroradiol"},{"key":"2525_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jocn.2018.10.096","volume":"59","author":"W Zhong","year":"2019","unstructured":"Zhong W, Huang Z, Tang X (2019) A study of brain MRI characteristics and clinical features in 76 cases of Wilson\u2019s disease. J Clin Neurosci 59:167\u2013174. https:\/\/doi.org\/10.1016\/j.jocn.2018.10.096","journal-title":"J Clin Neurosci"},{"issue":"6","key":"2525_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mds.22689","volume":"25","author":"LK Prashanth","year":"2010","unstructured":"Prashanth LK, Sinha S, Taly AB, Vasudev MK (2010) Do MRI features distinguish Wilson\u2019s disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Mov Disord 25(6):672\u2013678. https:\/\/doi.org\/10.1002\/mds.22689","journal-title":"Mov Disord"},{"issue":"1","key":"2525_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1179\/1476830512Y.0000000028","volume":"16","author":"J Kalita","year":"2013","unstructured":"Kalita J, Agarwal R, Chandra S, Misra UK (2013) A study of neurobehavioral, clinical psychometric, and P3 changes in vitamin B12 deficiency neurological syndrome. Nutr Neurosci 16(1):39\u201346. https:\/\/doi.org\/10.1179\/1476830512Y.0000000028","journal-title":"Nutr Neurosci"},{"key":"2525_CR15","doi-asserted-by":"publisher","unstructured":"Nagasaka H, Takayanagi M, Tsukahara H (2009) Children's toxicology from bench to bed\u2014liver Injury (3): oxidative stress and anti-oxidant systems in liver of patients with Wilson disease. J Toxicol Sci 34 Suppl 2:SP229\u2013236. https:\/\/doi.org\/10.2131\/jts.34.sp229","DOI":"10.2131\/jts.34.sp229"},{"issue":"10","key":"2525_CR16","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1007\/s12035-015-9570-y","volume":"53","author":"J Kalita","year":"2016","unstructured":"Kalita J, Kumar V, Misra UK (2016) A study on apoptosis and anti-apoptotic status in Wilson disease. Mol Neurobiol 53(10):6659\u20136667. https:\/\/doi.org\/10.1007\/s12035-015-9570-y","journal-title":"Mol Neurobiol"},{"issue":"5","key":"2525_CR17","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1007\/s12035-017-0619-y","volume":"55","author":"J Kalita","year":"2018","unstructured":"Kalita J, Kumar V, Misra UK, Bora HK (2018) Memory and learning dysfunction following copper toxicity: biochemical and immunohistochemical basis. Mol Neurobiol 55(5):3800\u20133811. https:\/\/doi.org\/10.1007\/s12035-017-0619-y","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2525_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s12640-019-00140-9","volume":"37","author":"J Kalita","year":"2020","unstructured":"Kalita J, Kumar V, Misra UK, Bora HK (2020) Movement disorder in copper toxicity rat model: role of inflammation and apoptosis in the corpus striatum. Neurotox Res 37(4):904\u2013912. https:\/\/doi.org\/10.1007\/s12640-019-00140-9","journal-title":"Neurotox Res"},{"issue":"2","key":"2525_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12031-020-01654-0","volume":"71","author":"J Kalita","year":"2021","unstructured":"Kalita J, Kumar V, Misra UK, Kumar S (2021) Movement disorder in Wilson disease: correlation with MRI and biomarkers of cell injury. J Mol Neuros: MN 71(2):338\u2013346. https:\/\/doi.org\/10.1007\/s12031-020-01654-0","journal-title":"J Mol Neurosci : MN"},{"issue":"5","key":"2525_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/mds.21392","volume":"22","author":"P Krystkowiak","year":"2007","unstructured":"Krystkowiak P, du Montcel ST, Vercueil L, Houeto JL, Lagrange C, Cornu P, Blond S, Benabid AL, et al (2007) Reliability of the Burke-Fahn-Marsden scale in a multicenter trial for dystonia. Mov Disord 22(5):685\u20139.https:\/\/doi.org\/10.1002\/mds.21392","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"2525_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2011.02.001","volume":"304","author":"J Kalita","year":"2011","unstructured":"Kalita J, Misra UK, Pradhan PK (2011) Oromandibular dystonia in encephalitis. J Neurol Sci 304(1\u20132):107\u2013110. https:\/\/doi.org\/10.1016\/j.jns.2011.02.001","journal-title":"J Neurol Sci"},{"key":"2525_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neuro.2018.12.005","volume":"71","author":"J Kalita","year":"2019","unstructured":"Kalita J, Misra UK, Kumar V, Parashar V (2019) Predictors of seizure in Wilson disease: a clinico-radiological and biomarkers study. Neurotoxicology 71:87\u201392. https:\/\/doi.org\/10.1016\/j.neuro.2018.12.005","journal-title":"Neurotoxicology"},{"key":"2525_CR23","doi-asserted-by":"publisher","unstructured":"Grimm G, Prayer L, Oder W, Ferenci P, Madl C, Knoflach P, Schneider B, Imhof H, et al (1991) Comparison of functional and structural brain disturbances in Wilson's disease. Neurology 41 (2 ( Pt 1)):272\u2013276. https:\/\/doi.org\/10.1212\/wnl.41.2_part_1.272","DOI":"10.1212\/wnl.41.2_part_1.272"},{"issue":"7","key":"2525_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/jnnp.53.7.628","volume":"53","author":"CM Wiles","year":"1990","unstructured":"Wiles CM (1990) Quantification of neurologic deficit. J Neurol Neurosurg Psychiatry 53(7):628\u2013628. https:\/\/doi.org\/10.1136\/jnnp.53.7.628","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"2525_CR25","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/wnl.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44(12):2308\u20132314. https:\/\/doi.org\/10.1212\/wnl.44.12.2308","journal-title":"Neurology"},{"issue":"5 Suppl 6","key":"2525_CR26","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1212\/wnl.48.5_suppl_6.10s","volume":"48","author":"JL Cummings","year":"1997","unstructured":"Cummings JL (1997) The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology 48(5 Suppl 6):S10-16. https:\/\/doi.org\/10.1212\/wnl.48.5_suppl_6.10s","journal-title":"Neurology"},{"key":"2525_CR27","doi-asserted-by":"publisher","unstructured":"Dening TR, Berrios GE (1989) Wilson's disease. Psychiatric symptoms in 195 cases. Arch Gen Psychiatry 46 (12):1126\u20131134. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810120068011","DOI":"10.1001\/archpsyc.1989.01810120068011"},{"issue":"5","key":"2525_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF00319740","volume":"238","author":"W Oder","year":"1991","unstructured":"Oder W, Grimm G, Kollegger H, Ferenci P, Schneider B, Deecke L (1991) Neurological and neuropsychiatric spectrum of Wilson\u2019s disease: a prospective study of 45 cases. J Neurol 238(5):281\u2013287. https:\/\/doi.org\/10.1007\/BF00319740","journal-title":"J Neurol"},{"issue":"10","key":"2525_CR29","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.parkreldis.2009.01.010","volume":"15","author":"M Svetel","year":"2009","unstructured":"Svetel M, Potrebic A, Pekmezovic T, Tomic A, Kresojevic N, Jesic R, Dragasevic N, Kostic VS (2009) Neuropsychiatric aspects of treated Wilson\u2019s disease. Parkinsonism Relat Disord 15(10):772\u2013775. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.01.010","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"2525_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/09540261.2017.1311845","volume":"29","author":"G Mura","year":"2017","unstructured":"Mura G, Zimbrean PC, Demelia L, Carta MG (2017) Psychiatric comorbidity in Wilson\u2019s disease. International review of psychiatry (Abingdon, England) 29(5):445\u2013462. https:\/\/doi.org\/10.1080\/09540261.2017.1311845","journal-title":"International review of psychiatry (Abingdon, England)"},{"issue":"1","key":"2525_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.genhosppsych.2013.08.007","volume":"36","author":"PC Zimbrean","year":"2014","unstructured":"Zimbrean PC, Schilsky ML (2014) Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry 36(1):53\u201362. https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.08.007","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"2525_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1034\/j.1600-0447.2000.90085.x","volume":"101","author":"K Portala","year":"2000","unstructured":"Portala K, Westermark K, von Knorring L, Ekselius L (2000) Psychopathology in treated Wilson\u2019s disease determined by means of CPRS expert and self-ratings. Acta Psychiatr Scand 101(2):104\u2013109. https:\/\/doi.org\/10.1034\/j.1600-0447.2000.90085.x","journal-title":"Acta Psychiatr Scand"},{"key":"2525_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/1745017901208010102","volume":"8","author":"M Carta","year":"2012","unstructured":"Carta M, Mura G, Sorbello O, Farina G, Demelia L (2012) Quality of life and psychiatric symptoms in Wilson\u2019s disease: the relevance of bipolar disorders. Clin Pract Epidemiol Ment Health 8:102\u2013109. https:\/\/doi.org\/10.2174\/1745017901208010102","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"6","key":"2525_CR34","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1192\/bjp.147.6.677","volume":"147","author":"TR Dening","year":"1985","unstructured":"Dening TR (1985) Psychiatric aspects of Wilson\u2019s disease. Br J Psychiatry 147(6):677\u2013682. https:\/\/doi.org\/10.1192\/bjp.147.6.677","journal-title":"Br J Psychiatry"},{"issue":"1","key":"2525_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jnnp.72.1.12","volume":"72","author":"HA Ring","year":"2002","unstructured":"Ring HA, Serra-Mestres J (2002) Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry 72(1):12\u201321. https:\/\/doi.org\/10.1136\/jnnp.72.1.12","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2525_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","volume":"71","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL (2001) Neuropsychiatric aspects of Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 71(3):310\u2013314. https:\/\/doi.org\/10.1136\/jnnp.71.3.310","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2525_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/brainsci7060067","volume":"7","author":"RA Paoli","year":"2017","unstructured":"Paoli RA, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C, Zugno E, Caletti E (2017) Neuropsychiatric burden in Huntington\u2019s disease. Brain Sci 7(6):67. https:\/\/doi.org\/10.3390\/brainsci7060067","journal-title":"Brain Sci"},{"issue":"1","key":"2525_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334. https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"issue":"6","key":"2525_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2217\/nmt-2017-0028","volume":"7","author":"RB Schneider","year":"2017","unstructured":"Schneider RB, Iourinets J, Richard IH (2017) Parkinson\u2019s disease psychosis: presentation, diagnosis and management. Neurodegener Dis Manag 7(6):365\u2013376. https:\/\/doi.org\/10.2217\/nmt-2017-0028","journal-title":"Neurodegener Dis Manag"},{"issue":"2","key":"2525_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/mp.2017.18","volume":"23","author":"F Imperiale","year":"2018","unstructured":"Imperiale F, Agosta F, Canu E, Markovic V, Inuggi A, Jecmenica-Lukic M, Tomic A, Copetti M, et al (2018) Brain structural and functional signatures of impulsive-compulsive behaviours in Parkinson\u2019s disease. Mol Psychiatry 23(2):459\u2013466. https:\/\/doi.org\/10.1038\/mp.2017.18","journal-title":"Mol Psychiatry"},{"key":"2525_CR41","doi-asserted-by":"publisher","unstructured":"Flavell J, Nestor PJ (2021) A systematic review of apathy and depression in progressive supranuclear palsy. J Geriatr Psychiatry Neurol:891988721993545. https:\/\/doi.org\/10.1177\/0891988721993545","DOI":"10.1177\/0891988721993545"},{"issue":"1","key":"2525_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1176\/appi.neuropsych.17010012","volume":"30","author":"M Jecmenica-Lukic","year":"2018","unstructured":"Jecmenica-Lukic M, Pekmezovic T, Petrovic IN, Tomic A, Svetel M, Kostic VS (2018) Use of the neuropsychiatric inventory to characterize the course of neuropsychiatric symptoms in progressive supranuclear palsy. J Neuropsychiatry Clin Neurosci 30(1):38\u201344. https:\/\/doi.org\/10.1176\/appi.neuropsych.17010012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"8","key":"2525_CR43","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1136\/jnnp.2003.019547","volume":"75","author":"T Benke","year":"2004","unstructured":"Benke T, Karner E, Seppi K, Delazer M, Marksteiner J, Donnemiller E (2004) Subacute dementia and imaging correlates in a case of Fahr\u2019s disease. J Neurol Neurosurg Psychiatry 75(8):1163\u20131165. https:\/\/doi.org\/10.1136\/jnnp.2003.019547","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"2525_CR44","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jaac.2017.01.010","volume":"56","author":"C Groth","year":"2017","unstructured":"Groth C, Mol Debes N, Rask CU, Lange T, Skov L (2017) Course of tourette syndrome and comorbidities in a large prospective clinical study. J Am Acad Child Adolesc Psychiatry 56(4):304\u2013312. https:\/\/doi.org\/10.1016\/j.jaac.2017.01.010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9082","key":"2525_CR45","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/s0140-6736(97)03148-6","volume":"350","author":"M Zeidler","year":"1997","unstructured":"Zeidler M, Johnstone EC, Bamber RW, Dickens CM, Fisher CJ, Francis AF, Goldbeck R, Higgo R, et al (1997) New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 350(9082):908\u2013910. https:\/\/doi.org\/10.1016\/s0140-6736(97)03148-6","journal-title":"Lancet"},{"issue":"7352","key":"2525_CR46","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/bmj.324.7352.1479","volume":"324","author":"MD Spencer","year":"2002","unstructured":"Spencer MD, Knight RS, Will RG (2002) First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 324(7352):1479\u20131482. https:\/\/doi.org\/10.1136\/bmj.324.7352.1479","journal-title":"BMJ"},{"key":"2525_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-021-01064-9","author":"M Pourhamzeh","year":"2021","unstructured":"Pourhamzeh M, Moravej FG, Arabi M, Shahriari E, Mehrabi S, Ward R, Ahadi R, Joghataei MT (2021) The roles of serotonin in neuropsychiatric disorders. Cell Mol Neurobiol. https:\/\/doi.org\/10.1007\/s10571-021-01064-9","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"2525_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00702-019-01987-0","volume":"126","author":"PB Foley","year":"2019","unstructured":"Foley PB (2019) Dopamine in psychiatry: a historical perspective. J Neural Transm (Vienna) 126(4):473\u2013479. https:\/\/doi.org\/10.1007\/s00702-019-01987-0","journal-title":"J Neural Transm (Vienna)"},{"issue":"5","key":"2525_CR49","first-page":"1066","volume":"26","author":"LT Lucato","year":"2005","unstructured":"Lucato LT, Otaduy MC, Barbosa ER, Machado AA, McKinney A, Bacheschi LA, Scaff M, Cerri GG, et al (2005) Proton MR spectroscopy in Wilson disease: analysis of 36 cases. AJNR Am J Neuroradiol 26(5):1066\u20131071","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"2525_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/0028-3886.132349","volume":"62","author":"S Pulai","year":"2014","unstructured":"Pulai S, Biswas A, Roy A, Guin DS, Pandit A, Gangopadhyay G, Ghorai PK, Sarkhel S, et al (2014) Clinical features, MRI brain, and MRS abnormalities of drug-naive neurologic Wilson\u2019s disease. Neurol India 62(2):153\u2013158. https:\/\/doi.org\/10.4103\/0028-3886.132349","journal-title":"Neurol India"},{"key":"2525_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.parkreldis.2016.06.017","volume":"30","author":"A Stezin","year":"2016","unstructured":"Stezin A, George L, Jhunjhunwala K, Lenka A, Saini J, Netravathi M, Yadav R, Pal PK (2016) Exploring cortical atrophy and its clinical and biochemical correlates in Wilson\u2019s disease using voxel based morphometry. Parkinsonism Relat Disord 30:52\u201357. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.06.017","journal-title":"Parkinsonism Relat Disord"},{"issue":"4S Suppl","key":"2525_CR52","doi-asserted-by":"publisher","first-page":"1007S","DOI":"10.1093\/jn\/130.4.1007S","volume":"130","author":"BS Meldrum","year":"2000","unstructured":"Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130(4S Suppl):1007S-1015S. https:\/\/doi.org\/10.1093\/jn\/130.4.1007S","journal-title":"J Nutr"},{"issue":"8","key":"2525_CR53","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","volume":"121","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Danbolt NC (2014) Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (Vienna) 121(8):799\u2013817. https:\/\/doi.org\/10.1007\/s00702-014-1180-8","journal-title":"J Neural Transm (Vienna)"},{"key":"2525_CR54","doi-asserted-by":"publisher","unstructured":"Magi S, Piccirillo S, Amoroso S, Lariccia V (2019) Excitatory amino acid transporters (EAATs): glutamate transport and beyond. Int J Mol Sci 20 (22). https:\/\/doi.org\/10.3390\/ijms20225674","DOI":"10.3390\/ijms20225674"},{"key":"2525_CR55","doi-asserted-by":"publisher","unstructured":"Hertz L (2006) Glutamate, a neurotransmitter\u2014and so much more. A synopsis of Wierzba III. Neurochem Int 48 (6\u20137):416\u2013425. https:\/\/doi.org\/10.1016\/j.neuint.2005.12.021","DOI":"10.1016\/j.neuint.2005.12.021"},{"issue":"9","key":"2525_CR56","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nrn916","volume":"3","author":"M Nedergaard","year":"2002","unstructured":"Nedergaard M, Takano T, Hansen AJ (2002) Beyond the role of glutamate as a neurotransmitter. Nat Rev Neurosci 3(9):748\u2013755. https:\/\/doi.org\/10.1038\/nrn916","journal-title":"Nat Rev Neurosci"},{"key":"2525_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2014.00080","volume":"8","author":"N Jensen","year":"2014","unstructured":"Jensen N, Oliveira JR (2014) Basal ganglia vulnerability to oxidative stress. Front Neurosci 8:80. https:\/\/doi.org\/10.3389\/fnins.2014.00080","journal-title":"Front Neurosci"},{"issue":"1","key":"2525_CR58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2249.2008.03755.x","volume":"154","author":"MK Goyal","year":"2008","unstructured":"Goyal MK, Sinha S, Patil SA, Jayalekshmy V, Taly AB (2008) Do cytokines have any role in Wilson\u2019s disease? Clin Exp Immunol 154(1):74\u201379. https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03755.x","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2525_CR59","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10072-018-3680-z","volume":"40","author":"P Wu","year":"2019","unstructured":"Wu P, Dong J, Cheng N, Yang R, Han Y, Han Y (2019) Inflammatory cytokines expression in Wilson\u2019s disease. Neurol Sci 40(5):1059\u20131066. https:\/\/doi.org\/10.1007\/s10072-018-3680-z","journal-title":"Neurol Sci"},{"issue":"4","key":"2525_CR60","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1203\/01.pdr.0000238341.12229.d3","volume":"60","author":"H Nagasaka","year":"2006","unstructured":"Nagasaka H, Inoue I, Inui A, Komatsu H, Sogo T, Murayama K, Murakami T, Yorifuji T, et al (2006) Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatr Res 60(4):472\u2013477. https:\/\/doi.org\/10.1203\/01.pdr.0000238341.12229.d3","journal-title":"Pediatr Res"},{"issue":"1","key":"2525_CR61","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbr069%JSchizophreniaBulletin","volume":"39","author":"A Marsman","year":"2011","unstructured":"Marsman A, van den Heuvel MP, Klomp DWJ, Kahn RS, Luijten PR, Hulshoff Pol HE (2011) Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr Bull 39(1):120\u2013129. https:\/\/doi.org\/10.1093\/schbul\/sbr069%JSchizophreniaBulletin","journal-title":"Schizophr Bull"},{"issue":"1","key":"2525_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon RA, Krystal JH, Howes OD (2020) Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry 19(1):15\u201333. https:\/\/doi.org\/10.1002\/wps.20693","journal-title":"World Psychiatry"},{"issue":"7","key":"2525_CR63","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrd.2017.16","volume":"16","author":"JW Murrough","year":"2017","unstructured":"Murrough JW, Abdallah CG, Mathew SJ (2017) Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov 16(7):472\u2013486. https:\/\/doi.org\/10.1038\/nrd.2017.16","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2525_CR64","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ajmg.b.32726","volume":"180","author":"X Huang","year":"2019","unstructured":"Huang X, Wang M, Zhang Q, Chen X, Wu J (2019) The role of glutamate receptors in attention-deficit\/hyperactivity disorder: from physiology to disease. Am J Med Genet B Neuropsychiatr Genet 180(4):272\u2013286. https:\/\/doi.org\/10.1002\/ajmg.b.32726","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"2525_CR65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41398-019-0500-z","volume":"9","author":"G Hasler","year":"2019","unstructured":"Hasler G, Buchmann A, Haynes M, Muller ST, Ghisleni C, Brechbuhl S, Tuura R (2019) Association between prefrontal glutamine levels and neuroticism determined using proton magnetic resonance spectroscopy. Transl Psychiatry 9(1):170. https:\/\/doi.org\/10.1038\/s41398-019-0500-z","journal-title":"Transl Psychiatry"},{"issue":"8","key":"2525_CR66","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.euroneuro.2015.04.016","volume":"25","author":"D Arnone","year":"2015","unstructured":"Arnone D, Mumuni AN, Jauhar S, Condon B, Cavanagh J (2015) Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: meta-analysis of absolute prefrontal neuro-metabolic concentrations. Eur Neuropsychopharmacol 25(8):1109\u20131117. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.04.016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"2525_CR67","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/0269881120965937","volume":"35","author":"KK Goh","year":"2021","unstructured":"Goh KK, Wu TH, Chen CH, Lu ML (2021) Efficacy of N-methyl-D-aspartate receptor modulator augmentation in schizophrenia: a meta-analysis of randomised, placebo-controlled trials. J Psychopharmacol 35(3):236\u2013252. https:\/\/doi.org\/10.1177\/0269881120965937","journal-title":"J Psychopharmacol"},{"issue":"10","key":"2525_CR68","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2165\/11586650-000000000-00000","volume":"25","author":"SP Singh","year":"2011","unstructured":"Singh SP, Singh V (2011) Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia. CNS Drugs 25(10):859\u2013885. https:\/\/doi.org\/10.2165\/11586650-000000000-00000","journal-title":"CNS Drugs"},{"issue":"1","key":"2525_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/schbul\/sbu132","volume":"41","author":"B Salavati","year":"2015","unstructured":"Salavati B, Rajji TK, Price R, Sun Y, Graff-Guerrero A, Daskalakis ZJ (2015) Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation. Schizophr Bull 41(1):44\u201356. https:\/\/doi.org\/10.1093\/schbul\/sbu132","journal-title":"Schizophr Bull"},{"issue":"2","key":"2525_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/bdi.12118","volume":"16","author":"AC Nugent","year":"2014","unstructured":"Nugent AC, Diazgranados N, Carlson PJ, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Drevets WC, Zarate CA Jr (2014) Neural correlates of rapid antidepressant response to ketamine in bipolar disorder. Bipolar Disord 16(2):119\u2013128. https:\/\/doi.org\/10.1111\/bdi.12118","journal-title":"Bipolar Disord"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02525-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02525-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02525-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T20:26:15Z","timestamp":1637180775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02525-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["2525"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02525-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"18 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research has been approved by the Institutional Ethics Committee (IEC), SGPGIMS, Lucknow, India (IEC Code: 2017\u2013216-DM-100).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}